The PCARE gene helps the retina’s light sensing cells build and maintain the outer segment, the part that captures light. This gene plays an important role in keeping these vision cells working over time. If the PCARE gene does not work properly, the cells can gradually wear down, which may lead to inherited retinal conditions such as retinitis pigmentosa or cone rod dystrophy. People with disease causing variants may notice night blindness, narrowing side vision, or gradual loss of central vision.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage activities in the body. Some genes hold the code for proteins, which are the functional parts of cells. Other genes mainly guide when certain processes happen, where they occur, and how active they are. As a group, genes affect how the body grows and works, and they can shape how you respond to food, stress, or medications. If you want to look into this topic more closely, you can find more in the LearnHub.
Overview
PCAREGene function
What if the gene works
The PCARE gene helps light sensing cells in the retina build and maintain the outer segments they need for vision. This supports the normal structure of rod and cone cells.
Risk
What if the gene does not work
Variants in the PCARE gene can cause retinal disease, most often retinitis pigmentosa and sometimes cone-rod dystrophy. Milder to more severe variants can influence when night blindness and vision loss begin, how fast they progress, and central versus peripheral vision.
Treatment
What does that mean for your treatment
No PCARE-specific treatment or management approach is currently established; treatment is guided by the person’s retinal findings rather than by a distinct drug choice linked to the PCARE gene.
Conditions associated with PCARE
Gene function
What if the gene works
In the retina, the PCARE gene supports the daily upkeep of the eye’s cells that sense light. Its protein works near the narrow link between parts of a photoreceptor, where new membrane is shaped for light detection. This helps these cells maintain the orderly surface they use to detect light.
The PCARE gene helps photoreceptors build and renew the outer segment (the part of the cell that catches light). This keeps fresh membrane disks forming in an orderly way so the cell can keep sensing light.
Near the cilium (a tiny bridge-like part of the cell), PCARE helps organize actin, a protein that gives cells shape and gentle pushing force. This support helps the cell mold membrane into the stacked layers used for vision.
Photoreceptor cells replace parts of their light-sensing surface every day. PCARE supports this steady remodeling, which is a central part of how the PCARE gene helps photoreceptor cells maintain normal structure over time.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PCARE gene can shorten the protein, make it unstable, or keep it from reaching the right part of light sensing retinal cells. In people reading about how PCARE gene variants affect vision, the main effect is disrupted formation and upkeep of the cells’ outer segment membranes. Some variants may leave partial protein activity, while more disruptive variants often lead to little or no working protein. This can influence how early an inherited retinal condition appears and how much it affects vision.
How variants are linked to conditions
Pathogenic variants in the PCARE gene are a well-established cause of inherited retinal conditions, especially retinitis pigmentosa and, in some families, cone-rod dystrophy. These eye conditions often begin with night blindness and reduced side vision, then may affect central vision over time. In this setting, variants in the PCARE gene linked to retinitis pigmentosa can confirm the genetic diagnosis when the eye findings fit.
A variant is not necessarily a diagnosis
Variants in genes are a common and normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental influences also play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PCARE, risk is mainly determined by the genes you inherit, especially having disease-causing changes in both copies of the gene. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower the chance of developing a PCARE-related eye condition. Regular eye care can still help catch changes early and support day-to-day vision needs.
Inheritance of PCARE variants
PCARE gene inheritance is most often autosomal recessive. This means a person usually inherits one PCARE gene variant from each parent, and parents who each carry one variant are often unaffected themselves. When both parents are carriers, each pregnancy has a 25% chance of a child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the PCARE gene is on chromosome 2, this pattern affects males and females equally.
What does my PCARE result mean for my family?
For families with a disease-causing PCARE result, close relatives may also carry the same gene change, even if they have no vision symptoms. Brothers and sisters may have the same eye condition or be carriers, and future children in the family could be affected if both parents carry a changed PCARE gene. Family testing can help clarify who else may be affected or carry the variant.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PCARE gene, doctors use genetic testing for PCARE variants on a blood or saliva sample. A lab reads the DNA sequence and reports whether a variant was found, which can help confirm an inherited retinal condition or clarify carrier status.
When should I consider getting a genetic test?
Genetic testing for the PCARE gene may be worth considering if you or your child has an inherited pattern of vision loss, especially night blindness, narrowing side vision, or a diagnosis such as retinitis pigmentosa. It can also help when several relatives have similar inherited eye disease or when the cause of ongoing vision changes is unclear.
A genetic result is only one part of your health story
A genetic result can be very informative, but what it tells you depends on the condition and on the type of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the way the body absorbs, breaks down, transports, or reacts to a drug can help explain why the same treatment works well for one person but less well for another. These differences are common and may influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can shape the way a person responds to medication. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the PCARE gene
When should I seek medical advice?
There is not yet a broadly confirmed link between changes in this gene and how medicines work, so any concerns about side effects, new symptoms, or medicine choices are best discussed with your doctor.
History
The PCARE gene first entered the medical literature under the name C2orf71 during efforts to identify genes involved in inherited retinal conditions. As genetic testing improved in the late 2000s and 2010s, researchers linked variants in this gene to forms of retinitis pigmentosa and cone rod dystrophy in affected families. In recent decades, awareness of this gene’s role has grown as studies connected earlier family based observations with a specific genetic cause. The name later changed to PCARE, short for photoreceptor cilium actin regulator, reflecting a clearer understanding of its place in eye research. From these first observations, research expanded steadily, helping place PCARE among the genes now recognized in inherited retinal disease.